Number of symptomatic UTIs During the 6-month follow-up [clinicaltrials_resource:106e6f63a8c8f3e9df8129f175221ff1]
Symptomatic UTIs are defined by the presence of infection or reinfection by the same bacteria, in combination with the presence of definite clinical signs of infection (autonomous hyper-reflexivity, spasticity, leakage, contractures, pyuria, fever, shivers).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of symptomatic UTIs During the 6-month follow-up [clinicaltrials_resource:106e6f63a8c8f3e9df8129f175221ff1]
Symptomatic UTIs are defined by the presence of infection or reinfection by the same bacteria, in combination with the presence of definite clinical signs of infection (autonomous hyper-reflexivity, spasticity, leakage, contractures, pyuria, fever, shivers).
Bio2RDF identifier
106e6f63a8c8f3e9df8129f175221ff1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:106e6f63a8c8f3e9df8129f175221ff1
measure [clinicaltrials_vocabulary:measure]
Number of symptomatic UTIs
time frame [clinicaltrials_vocabulary:time-frame]
During the 6-month follow-up
description
Symptomatic UTIs are defined b ...... ures, pyuria, fever, shivers).
identifier
clinicaltrials_resource:106e6f63a8c8f3e9df8129f175221ff1
title
Number of symptomatic UTIs During the 6-month follow-up
@en
type
label
Number of symptomatic UTIs Dur ...... e6f63a8c8f3e9df8129f175221ff1]
@en